Supporting our hypothesis are data derived from LRRK2 variant carriers, who have a higher prevalence of prediabetes and elevated triglyceride levels compared to non-carriers and individuals with PD due to other genetic mutations [77]. The gene discussed is LRRK2; the disease is prediabetes syndrome.